Formed in 2011, Nestlé Health Science is a health-science company engaged in advancing the role of nutritional therapy to change the course of health for consumers, patients and our partners in healthcare.
Through investing in innovation and leveraging leading edge science, we are striving to forge a new industry based upon inherently safe nutritional therapies with relevant levels of quality of life benefits and proven clinical and health economic value.
Nestlé Health Science is a global company, headquartered in Vevey (Switzerland) and employing around 3000 people worldwide. The company was initially founded on the HealthCare Nutrition business of the Nestlé Group. Already, through our portfolio of consumer care and medical nutrition brands every day we address the specific nutritional needs of many people.
To build a transformational pipeline, we are actively involved in identifying and commercialising fundamental scientific advances being in understanding how nutrients can be used to impact disease at a cellular level – with potentially greater therapeutic impact. Our activities to date include a number of acquisitions and investments: Vitaflo – portfolio of clinical nutritional solutions for metabolic disorders (especially inborn errors of metabolism, IEM); Prometheus Laboratories – diagnostics and pharmaceuticals in gastroenterology (GI) and oncology; Pamlab – prescription medical foods for the brain and metabolic disorders; Nutrition Science Partners (joint venture) – exploring the potential of botanical-based nutrients, focusing on gastrointestinal disorders; and Accera (minority stake) – supporting trials of a nutritional therapy for people suffering from Alzheimer’s disease.
With access to the research of Nestlé Institute of Health Sciences set-up simultaneously with our own company, and the taste and nutritional expertise of the Nestlé Group to draw upon – we are well positioned to fulfil our ambitions through innovative nutritional therapies.